Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tillmann Krahnke
Imatinib Pharmacokinetics and Its Correlation With Response and Safety in Chronic-Phase Chronic Myeloid Leukemia: A Subanalysis of the IRIS Study
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Polycomb Genes Are Associated With Response to Imatinib in Chronic Myeloid Leukemia
Epigenomics
Cancer Research
Genetics
Long-Term Safety and Efficacy of Dasatinib in the Treatment of Chronic-Phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib
Blood and Lymphatic Cancer: Targets and Therapy
Influence of CYP3A5 and Drug Transporter Polymorphisms on Imatinib Trough Concentration and Clinical Response Among Patients With Chronic Phase Chronic Myeloid Leukemia
Journal of Human Genetics
Genetics
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Failure of a Non-Authorized Copy Product to Maintain Response Achieved With Imatinib in a Patient With Chronic Phase Chronic Myeloid Leukemia: A Case Report
Journal of Medical Case Reports
Medicine
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Imatinib and Plasmacytoid Dendritic Cell Function in Patients With Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
